VERA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,681,787.73

Vera Therapeutics Insider Trading History Chart

Vera Therapeutics Share Price & Price History

^$22.43

▲ +0.62 (2.84%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Vera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/8/2025	Marshall Fordyce	CEO	Sell	17,500	$41.74	$730,450.00	143,603
12/18/2024	Marshall Fordyce	CEO	Sell	17,500	$43.07	$753,725.00	85,942
12/11/2024	Marshall Fordyce	CEO	Sell	17,500	$46.94	$821,450.00	85,942
10/28/2024	Beth C Seidenberg	Director	Sell	15,000	$48.03	$720,450.00	131,553
10/23/2024	Marshall Fordyce	CEO	Sell	19,375	$40.39	$782,556.25	307,972
10/9/2024	Marshall Fordyce	CEO	Sell	15,625	$38.24	$597,500.00	307,972
9/25/2024	Marshall Fordyce	CEO	Sell	23,125	$46.05	$1,064,906.25	307,972
9/18/2024	Beth C Seidenberg	Director	Sell	1,177	$42.01	$49,445.77	160,376
9/11/2024	Marshall Fordyce	CEO	Sell	15,625	$37.50	$585,937.50	307,972
8/21/2024	Marshall Fordyce	CEO	Sell	14,471	$39.76	$575,366.96	322,667
4/10/2024	Joseph R. Young	SVP	Sell	5,714	$40.00	$228,560.00	53,171
4/3/2024	Sean Grant	CFO	Sell	99,828	$39.61	$3,954,187.08	66,337
3/25/2024	Maha Katabi	Director	Sell	340,000	$40.50	$13,770,000.00	2,793,987
3/21/2024	Maha Katabi	Director	Sell	81,009	$44.20	$3,580,597.80	3,547,437
1/30/2024	Maha Katabi	Director	Buy	161,290	$31.00	$4,999,990.00	3,628,446
1/10/2024	Commodore Capital Lp	Major Shareholder	Sell	1,050,000	$18.00	$18,900,000.00	4,400,000
8/21/2023	Celia Lin	Insider	Sell	1,490	$16.65	$24,808.50	11,010
8/21/2023	Marshall Fordyce	CEO	Sell	5,210	$16.66	$86,798.60	243,361
6/23/2023	Sean Grant	CFO	Buy	5,000	$16.60	$83,000.00	5,992
6/20/2023	Commodore Capital Lp	Major Shareholder	Buy	448,217	$15.17	$6,799,451.89	5,450,000
3/30/2023	Beth C Seidenberg	Director	Buy	2,300	$7.24	$16,652.00	1,949,295
3/27/2023	Beth C Seidenberg	Director	Buy	1,633	$7.24	$11,822.92	1,923,087
3/24/2023	Beth C Seidenberg	Director	Buy	1,833	$7.24	$13,270.92	1,921,454
3/20/2023	Beth C Seidenberg	Director	Buy	15,252	$7.21	$109,966.92	1,919,621
3/17/2023	Beth C Seidenberg	Director	Buy	74,045	$7.12	$527,200.40	1,904,369
3/15/2023	Beth C Seidenberg	Director	Buy	32,844	$7.12	$233,849.28	1,770,227
3/10/2023	Beth C Seidenberg	Director	Buy	48,003	$7.16	$343,701.48	1,737,383
3/3/2023	Beth C Seidenberg	Director	Buy	1,000	$7.25	$7,250.00	1,689,380
3/1/2023	Beth C Seidenberg	Director	Buy	100	$7.25	$725.00	1,665,002
2/23/2023	Beth C Seidenberg	Director	Buy	200	$7.24	$1,448.00	1,664,902
2/13/2023	Beth C Seidenberg	Director	Buy	10,072	$7.20	$72,518.40	1,664,702
2/8/2023	Beth C Seidenberg	Director	Buy	45,357	$7.22	$327,477.54	1,654,230
2/6/2023	Patrick G Enright	Director	Buy	1,714,285	$7.00	$11,999,995.00	1,714,285
2/6/2023	Sofinnova Venture Partners X,	Major Shareholder	Buy	285,714	$7.00	$1,999,998.00	3,467,156
2/3/2023	Beth C Seidenberg	Director	Buy	46,163	$7.24	$334,220.12	1,389,315
12/16/2022	Joanne Curley	Insider	Sell	2,212	$19.49	$43,111.88	26,821
11/17/2022	Joanne Curley	Insider	Sell	3,289	$15.85	$52,130.65	27,315
10/18/2022	Joanne Curley	Insider	Sell	8,590	$19.41	$166,731.90	27,809
10/5/2022	Joanne Curley	Insider	Sell	988	$21.64	$21,380.32	27,809
10/4/2022	Marshall Fordyce	CEO	Sell	18,223	$21.19	$386,145.37	181,150
9/20/2022	Joanne Curley	Insider	Sell	15,666	$20.67	$323,816.22	28,797
9/12/2022	Marshall Fordyce	CEO	Sell	16,136	$20.64	$333,047.04	181,150
9/8/2022	Marshall Fordyce	CEO	Sell	15,106	$20.52	$309,975.12	181,150
8/22/2022	Joanne Curley	Insider	Sell	1,630	$18.87	$30,758.10	29,785
8/19/2022	Joanne Curley	Insider	Sell	6,909	$19.20	$132,652.80	29,785
8/17/2022	Carlyle Group Inc.	Major Shareholder	Sell	9,925	$20.25	$200,981.25	2,960,231
8/12/2022	Marshall Fordyce	CEO	Sell	20,528	$20.16	$413,844.48	137,400
8/3/2022	Joanne Curley	Insider	Sell	988	$16.81	$16,608.28	17,285
7/19/2022	Joanne Curley	Insider	Sell	11,444	$16.01	$183,218.44	18,273
7/14/2022	Joanne Curley	Insider	Sell	9,104	$15.14	$137,834.56	18,273
7/7/2022	Joanne Curley	Insider	Sell	9,666	$15.05	$145,473.30	21,023
6/22/2022	Joanne Curley	Insider	Sell	1,545	$15.01	$23,190.45	23,688
6/17/2022	Joanne Curley	Insider	Sell	5,887	$15.04	$88,540.48	23,994
6/15/2022	Sean Grant	CFO	Buy	5,000	$13.60	$68,000.00	2,816

See Full Table

SEC Filings (Institutional Ownership Changes) for Vera Therapeutics (NASDAQ:VERA)

99.21% of Vera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/8/2025	Rhumbline Advisers	63,189	$1.52M	0.0%	+7.9%	0.099%
4/7/2025	GAMMA Investing LLC	8,287	$0.20M	0.0%	+1,779.1%	0.013%
3/24/2025	Wellington Management Group LLP	18,018	$0.76M	0.0%	-10.2%	0.028%
3/18/2025	California State Teachers Retirement System	40,640	$1.72M	0.0%	+19.9%	0.064%
2/19/2025	GF Fund Management CO. LTD.	1,330	$56K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	80,106	$3.39M	0.0%	+30.1%	0.127%
2/17/2025	Woodline Partners LP	1,202,466	$50.85M	0.3%	+20.1%	1.899%
2/17/2025	Vestal Point Capital LP	1,075,000	$45.46M	2.7%	N/A	1.698%
2/17/2025	Wexford Capital LP	43,521	$1.84M	0.3%	-7.1%	0.069%
2/17/2025	Two Sigma Investments LP	41,451	$1.75M	0.0%	-14.6%	0.065%
2/17/2025	Thornburg Investment Management Inc.	59,004	$2.50M	0.0%	+91.1%	0.093%
2/17/2025	Sandia Investment Management LP	10,000	$0.42M	1.0%	N/A	0.016%
2/17/2025	Rafferty Asset Management LLC	87,686	$3.71M	0.0%	+11.1%	0.138%
2/17/2025	Point72 Asset Management L.P.	194,027	$8.21M	0.0%	+13.1%	0.306%
2/17/2025	ProShare Advisors LLC	15,487	$0.66M	0.0%	+46.0%	0.024%
2/17/2025	MPM Bioimpact LLC	257,788	$10.90M	1.5%	N/A	0.407%
2/17/2025	Paradigm Biocapital Advisors LP	1,437,339	$60.79M	2.1%	+31.0%	2.270%
2/17/2025	Nuveen Asset Management LLC	155,825	$6.59M	0.0%	-2.0%	0.246%
2/17/2025	Nicholas Investment Partners LP	106,805	$4.52M	0.4%	+49.3%	0.169%
2/17/2025	Orbimed Advisors LLC	742,572	$31.40M	0.7%	+9.9%	1.173%
2/17/2025	Millennium Management LLC	77,648	$3.28M	0.0%	-73.8%	0.123%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	28,695	$1.21M	0.0%	+34.6%	0.045%
2/17/2025	Integral Health Asset Management LLC	1,150,000	$48.63M	4.1%	+130.0%	1.816%
2/17/2025	Janus Henderson Group PLC	21,735	$0.92M	0.0%	+49.9%	0.034%
2/17/2025	Ensign Peak Advisors Inc	13,550	$0.57M	0.0%	+15.3%	0.021%
2/17/2025	D. E. Shaw & Co. Inc.	74,476	$3.15M	0.0%	-42.9%	0.118%
2/17/2025	Deutsche Bank AG	810,376	$34.27M	0.0%	+5.7%	1.280%
2/17/2025	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	10,182	$0.43M	0.0%	N/A	0.016%
2/17/2025	Crestline Management LP	160,347	$6.78M	0.2%	+97.2%	0.253%
2/17/2025	Cubist Systematic Strategies LLC	56,921	$2.41M	0.0%	-44.2%	0.090%
2/17/2025	Cutter Capital Management LP	212,696	$9M	3.7%	+23.0%	0.336%
2/17/2025	Brevan Howard Capital Management LP	5,504	$0.23M	0.0%	-27.7%	0.009%
2/17/2025	Balyasny Asset Management L.P.	385,425	$16.30M	0.0%	+119.5%	0.609%
2/17/2025	Bank of America Corp DE	30,244	$1.28M	0.0%	-77.9%	0.048%
2/17/2025	BNP Paribas Financial Markets	24,374	$1.03M	0.0%	N/A	0.038%
2/17/2025	Ameriprise Financial Inc.	30,021	$1.27M	0.0%	+31.7%	0.047%
2/17/2025	Algert Global LLC	38,550	$1.63M	0.0%	+66.4%	0.061%
2/17/2025	AXA S.A.	245,879	$10.40M	0.0%	-0.2%	0.388%
2/14/2025	Schonfeld Strategic Advisors LLC	116,915	$4.94M	0.0%	-40.5%	0.185%
2/14/2025	First Light Asset Management LLC	1,261,246	$53.34M	5.1%	+78.8%	1.992%
2/14/2025	Northern Trust Corp	455,007	$19.24M	0.0%	+24.6%	0.719%
2/14/2025	The Manufacturers Life Insurance Company	128,380	$5.43M	0.0%	+26.0%	0.203%
2/14/2025	Tudor Investment Corp ET AL	31,843	$1.35M	0.0%	+30.1%	0.050%
2/14/2025	Decheng Capital LLC	49,767	$2.11M	0.5%	-28.7%	0.079%
2/14/2025	Boothbay Fund Management LLC	24,722	$1.05M	0.0%	N/A	0.039%
2/14/2025	Virtus ETF Advisers LLC	1,576	$67K	0.0%	-36.1%	0.002%
2/14/2025	Lord Abbett & CO. LLC	1,153,670	$48.79M	0.2%	+170.8%	1.822%
2/14/2025	Voya Investment Management LLC	695,091	$29.40M	0.0%	+572.2%	1.098%
2/14/2025	Adage Capital Partners GP L.L.C.	480,000	$20.30M	0.0%	-65.1%	0.758%
2/14/2025	T. Rowe Price Investment Management Inc.	1,415,179	$59.85M	0.0%	+43.8%	2.235%
2/14/2025	Price T Rowe Associates Inc. MD	4,377,049	$185.11M	0.0%	+11.1%	6.913%
2/14/2025	Eversept Partners LP	1,600,015	$67.67M	6.0%	-22.0%	2.527%
2/14/2025	Hsbc Holdings PLC	6,228	$0.26M	0.0%	N/A	0.010%
2/14/2025	Avoro Capital Advisors LLC	5,610,000	$237.25M	3.4%	+30.2%	8.860%
2/14/2025	Rock Springs Capital Management LP	487,863	$20.63M	0.8%	+27.2%	0.770%
2/14/2025	Tower Research Capital LLC TRC	10,475	$0.44M	0.0%	+4,264.6%	0.017%
2/14/2025	MetLife Investment Management LLC	26,803	$1.13M	0.0%	+17.7%	0.042%
2/14/2025	Dimensional Fund Advisors LP	15,832	$0.67M	0.0%	-10.7%	0.025%
2/14/2025	Altium Capital Management LLC	432,000	$18.27M	5.2%	-36.8%	0.682%
2/13/2025	Marshall Wace LLP	837,146	$35.40M	0.0%	+43.4%	1.322%
2/13/2025	Affinity Asset Advisors LLC	425,000	$17.97M	2.4%	-2.3%	0.671%
2/13/2025	Barclays PLC	99,148	$4.19M	0.0%	+16.1%	0.157%
2/13/2025	Summit Investment Advisors Inc.	4,639	$0.20M	0.2%	+16.0%	0.007%
2/13/2025	Optimize Financial Inc	5,895	$0.25M	0.2%	N/A	0.009%
2/13/2025	Raymond James Financial Inc.	69,724	$2.95M	0.0%	N/A	0.110%
2/13/2025	Renaissance Technologies LLC	35,700	$1.51M	0.0%	N/A	0.056%
2/13/2025	Legal & General Group Plc	47,809	$2.02M	0.0%	+9.7%	0.076%
2/13/2025	Invesco Ltd.	21,954	$0.93M	0.0%	+7.0%	0.035%
2/13/2025	FMR LLC	3,053,126	$129.12M	0.0%	+9.6%	4.822%
2/13/2025	Federated Hermes Inc.	1,085,986	$45.93M	0.1%	+162.2%	1.715%
2/13/2025	Springhill Fund Asset Management HK Co Ltd	109,400	$4.63M	7.5%	N/A	0.173%
2/13/2025	Wells Fargo & Company MN	39,576	$1.67M	0.0%	+229.7%	0.063%
2/12/2025	Cinctive Capital Management LP	113,546	$4.80M	0.2%	+134.1%	0.179%
2/12/2025	Huntington National Bank	615	$26K	0.0%	N/A	0.001%
2/12/2025	Trexquant Investment LP	21,864	$0.93M	0.0%	-57.8%	0.035%
2/12/2025	Geode Capital Management LLC	1,153,325	$48.79M	0.0%	+14.8%	1.821%
2/12/2025	Alliancebernstein L.P.	40,350	$1.71M	0.0%	+2.0%	0.064%
2/12/2025	Wellington Management Group LLP	18,018	$0.76M	0.0%	-10.2%	0.028%
2/12/2025	Schroder Investment Management Group	485,145	$20.41M	0.0%	+1.8%	0.766%
2/12/2025	Pictet Asset Management Holding SA	841,313	$35.58M	0.0%	+47.1%	1.329%
2/12/2025	Norges Bank	48,593	$2.06M	0.0%	N/A	0.077%
2/12/2025	JPMorgan Chase & Co.	221,485	$9.37M	0.0%	+71.6%	0.350%
2/11/2025	Pier Capital LLC	102,128	$4.32M	0.6%	-1.3%	0.161%
2/11/2025	EFG Asset Management North America Corp.	73,160	$3.09M	0.4%	+59.2%	0.116%
2/11/2025	Prudential Financial Inc.	83,077	$3.51M	0.0%	+33.6%	0.131%
2/11/2025	Corebridge Financial Inc.	22,047	$0.93M	0.0%	+5.8%	0.035%
2/11/2025	Vanguard Group Inc.	2,949,564	$124.74M	0.0%	+14.3%	4.658%
2/11/2025	KLP Kapitalforvaltning AS	10,200	$0.43M	0.0%	N/A	0.016%
2/11/2025	American Century Companies Inc.	428,940	$18.14M	0.0%	+11.0%	0.677%
2/11/2025	Teacher Retirement System of Texas	12,860	$0.54M	0.0%	+44.2%	0.020%
2/11/2025	Platinum Investment Management Ltd.	119,664	$5.06M	0.3%	-12.9%	0.189%
2/10/2025	Skandinaviska Enskilda Banken AB publ	22,290	$0.94M	0.0%	+30.3%	0.035%
2/10/2025	Swiss National Bank	85,400	$3.61M	0.0%	+22.5%	0.135%
2/7/2025	Moors & Cabot Inc.	5,200	$0.22M	0.0%	N/A	0.008%
2/7/2025	AlphaQuest LLC	794	$34K	0.0%	N/A	0.001%
2/7/2025	E Fund Management Co. Ltd.	6,203	$0.26M	0.0%	+22.3%	0.010%
2/7/2025	Candriam S.C.A.	365,999	$15.48M	0.1%	-18.8%	0.578%
2/6/2025	Raymond James Financial Inc.	69,724	$2.95M	0.0%	N/A	0.110%
2/6/2025	Arizona State Retirement System	12,586	$0.53M	0.0%	+22.9%	0.020%
2/6/2025	Victory Capital Management Inc.	235,267	$9.95M	0.0%	+515.0%	0.372%

Data available starting January 2016

See Full Table

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Today's Range

Now: $22.43

$20.94

$23.33

50 Day Range

MA: $27.58

$18.86

$38.11

52 Week Range

Now: $22.43

$18.53

$51.61

Volume

1,535,188 shs

Average Volume

763,953 shs

Market Capitalization

$1.43 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Vera Therapeutics?: Vera Therapeutics' top insider shareholders include:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Marshall Fordyce (CEO)
Beth C Seidenberg (Director)
Sean Grant (CFO)
Joseph R Young (SVP)
Celia Lin (Insider)
Learn More about top insider investors at Vera Therapeutics.
Who are the major institutional investors of Vera Therapeutics?: Vera Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.10%
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Vera Therapeutics stock.
Which major investors are buying Vera Therapeutics stock?: During the last quarter, VERA stock was bought by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers
In the previous year, these company insiders have bought Vera Therapeutics stock:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Marshall Fordyce (CEO)
Learn More investors buying Vera Therapeutics stock.